Annual Net Income:
-$320.63M+$55.70M(+14.80%)Summary
- As of today, TVTX annual net profit is -$320.63 million, with the most recent change of +$55.70 million (+14.80%) on December 31, 2024.
- During the last 3 years, TVTX annual net income has fallen by -$140.54 million (-78.04%).
- TVTX annual net income is now -373.49% below its all-time high of $117.24 million, reached on December 31, 2015.
Performance
TVTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$25.71M+$38.46M(+301.54%)Summary
- As of today, TVTX quarterly net profit is $25.71 million, with the most recent change of +$38.46 million (+301.54%) on September 30, 2025.
- Over the past year, TVTX quarterly net income has increased by +$80.46 million (+146.95%).
- TVTX quarterly net income is now -75.65% below its all-time high of $105.58 million, reached on September 30, 2015.
Performance
TVTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$88.54M+$80.46M(+47.61%)Summary
- As of today, TVTX TTM net profit is -$88.54 million, with the most recent change of +$80.46 million (+47.61%) on September 30, 2025.
- Over the past year, TVTX TTM net income has increased by +$260.42 million (+74.63%).
- TVTX TTM net income is now -175.52% below its all-time high of $117.24 million, reached on December 31, 2015.
Performance
TVTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TVTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +14.8% | +146.9% | +74.6% |
| 3Y3 Years | -78.0% | +130.6% | +68.2% |
| 5Y5 Years | -119.0% | +214.0% | -13.4% |
TVTX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -78.0% | +14.8% | at high | +118.9% | at high | +77.8% |
| 5Y | 5-Year | -119.0% | +14.8% | at high | +118.9% | -13.4% | +77.8% |
| All-Time | All-Time | -373.5% | +14.8% | -75.7% | +118.9% | -175.5% | +77.8% |
TVTX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $25.71M(+301.5%) | -$88.54M(+47.6%) |
| Jun 2025 | - | -$12.76M(+69.1%) | -$169.00M(+25.2%) |
| Mar 2025 | - | -$41.23M(+31.6%) | -$225.90M(+29.5%) |
| Dec 2024 | -$320.63M(+14.8%) | -$60.27M(-10.1%) | -$320.63M(+8.1%) |
| Sep 2024 | - | -$54.75M(+21.4%) | -$348.96M(+9.0%) |
| Jun 2024 | - | -$69.65M(+48.8%) | -$383.45M(+4.0%) |
| Mar 2024 | - | -$135.96M(-53.5%) | -$399.43M(-10.9%) |
| Dec 2023 | -$376.33M(-13.5%) | -$88.60M(+0.7%) | -$360.03M(-0.8%) |
| Sep 2023 | - | -$89.24M(-4.2%) | -$357.07M(-1.5%) |
| Jun 2023 | - | -$85.63M(+11.3%) | -$351.89M(-5.6%) |
| Mar 2023 | - | -$96.56M(-12.8%) | -$333.30M(-6.6%) |
| Dec 2022 | -$331.47M(-84.1%) | -$85.64M(-1.9%) | -$312.70M(-12.2%) |
| Sep 2022 | - | -$84.06M(-25.4%) | -$278.64M(-21.0%) |
| Jun 2022 | - | -$67.03M(+11.8%) | -$230.22M(-13.9%) |
| Mar 2022 | - | -$75.97M(-47.3%) | -$202.19M(-12.3%) |
| Dec 2021 | -$180.09M(-6.3%) | -$51.57M(-44.7%) | -$180.09M(+28.0%) |
| Sep 2021 | - | -$35.64M(+8.6%) | -$250.14M(-5.5%) |
| Jun 2021 | - | -$39.01M(+27.6%) | -$237.05M(-5.8%) |
| Mar 2021 | - | -$53.87M(+55.7%) | -$224.11M(-32.3%) |
| Dec 2020 | -$169.43M(-15.7%) | -$121.62M(-439.4%) | -$169.43M(-117.0%) |
| Sep 2020 | - | -$22.55M(+13.5%) | -$78.07M(+15.2%) |
| Jun 2020 | - | -$26.07M(-3326.2%) | -$92.01M(+12.1%) |
| Mar 2020 | - | $808.00K(+102.7%) | -$104.64M(+28.5%) |
| Dec 2019 | -$146.43M(-42.6%) | -$30.26M(+17.1%) | -$146.43M(-18.4%) |
| Sep 2019 | - | -$36.49M(+5.7%) | -$123.62M(+12.7%) |
| Jun 2019 | - | -$38.70M(+5.6%) | -$141.65M(-13.1%) |
| Mar 2019 | - | -$40.98M(-449.7%) | -$125.28M(-22.0%) |
| Dec 2018 | -$102.68M(-71.9%) | -$7.46M(+86.3%) | -$102.68M(+9.0%) |
| Sep 2018 | - | -$54.52M(-144.1%) | -$112.84M(-48.2%) |
| Jun 2018 | - | -$22.33M(-21.5%) | -$76.12M(-13.6%) |
| Mar 2018 | - | -$18.38M(-4.3%) | -$67.02M(-12.2%) |
| Dec 2017 | -$59.73M | -$17.62M(+1.0%) | -$59.73M(-17.8%) |
| Sep 2017 | - | -$17.79M(-34.5%) | -$50.72M(+27.6%) |
| Jun 2017 | - | -$13.23M(-19.3%) | -$70.03M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$11.09M(-28.9%) | -$70.21M(-46.6%) |
| Dec 2016 | -$47.90M(-140.9%) | -$8.60M(+76.8%) | -$47.90M(-14.7%) |
| Sep 2016 | - | -$37.11M(-176.9%) | -$41.77M(-141.4%) |
| Jun 2016 | - | -$13.40M(-219.5%) | $100.92M(+13.7%) |
| Mar 2016 | - | $11.22M(+554.3%) | $88.80M(-24.3%) |
| Dec 2015 | $117.24M(+205.7%) | -$2.47M(-102.3%) | $117.24M(+29.3%) |
| Sep 2015 | - | $105.58M(+513.6%) | $90.68M(+363.2%) |
| Jun 2015 | - | -$25.53M(-164.4%) | -$34.46M(-7632.4%) |
| Mar 2015 | - | $39.66M(+236.6%) | -$445.60K(+99.6%) |
| Dec 2014 | -$110.94M(-220.4%) | -$29.03M(-48.4%) | -$110.73M(-17.1%) |
| Sep 2014 | - | -$19.56M(-330.5%) | -$94.52M(-10.1%) |
| Jun 2014 | - | $8.48M(+112.0%) | -$85.86M(+13.6%) |
| Mar 2014 | - | -$70.63M(-450.8%) | -$99.39M(-196.6%) |
| Dec 2013 | -$34.62M(-14.1%) | -$12.82M(-17.7%) | -$33.51M(+34.3%) |
| Sep 2013 | - | -$10.90M(-115.9%) | -$51.02M(-27.2%) |
| Jun 2013 | - | -$5.05M(-6.4%) | -$40.12M(-14.4%) |
| Mar 2013 | - | -$4.74M(+84.4%) | -$35.08M(-15.6%) |
| Dec 2012 | -$30.34M(>-9900.0%) | -$30.33M(>-9900.0%) | -$30.33M(>-9900.0%) |
| Nov 2011 | - | -$3500.00(0.0%) | -$14.60K(+13.1%) |
| Aug 2011 | - | -$3500.00(0.0%) | -$16.80K(+15.6%) |
| May 2011 | - | -$3500.00(+14.6%) | -$19.90K(+13.5%) |
| Feb 2011 | -$23.00K(+17.9%) | -$4100.00(+28.1%) | -$23.00K(+11.2%) |
| Nov 2010 | - | -$5700.00(+13.6%) | -$25.90K(+3.4%) |
| Aug 2010 | - | -$6600.00(0.0%) | -$26.80K(+0.4%) |
| May 2010 | - | -$6600.00(+5.7%) | -$26.90K(+3.6%) |
| Feb 2010 | -$28.00K(-53.0%) | -$7000.00(-6.1%) | -$27.90K(+2.1%) |
| Nov 2009 | - | -$6600.00(+1.5%) | -$28.50K(-8.8%) |
| Aug 2009 | - | -$6700.00(+11.8%) | -$26.20K(-15.9%) |
| May 2009 | - | -$7600.00(0.0%) | -$22.60K(-22.8%) |
| Feb 2009 | -$18.30K(+64.8%) | -$7600.00(-76.7%) | -$18.40K(-70.4%) |
| Nov 2008 | - | -$4300.00(-38.7%) | -$10.80K(-66.2%) |
| Aug 2008 | - | -$3100.00(+8.8%) | -$6500.00(-91.2%) |
| May 2008 | - | -$3400.00 | -$3400.00 |
| Feb 2008 | -$52.00K | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual net profit?
- What is the all-time high annual net income for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual net income year-on-year change?
- What is Travere Therapeutics, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly net income year-on-year change?
- What is Travere Therapeutics, Inc. TTM net profit?
- What is the all-time high TTM net income for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM net income year-on-year change?
What is Travere Therapeutics, Inc. annual net profit?
The current annual net income of TVTX is -$320.63M
What is the all-time high annual net income for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual net profit is $117.24M
What is Travere Therapeutics, Inc. annual net income year-on-year change?
Over the past year, TVTX annual net profit has changed by +$55.70M (+14.80%)
What is Travere Therapeutics, Inc. quarterly net profit?
The current quarterly net income of TVTX is $25.71M
What is the all-time high quarterly net income for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly net profit is $105.58M
What is Travere Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, TVTX quarterly net profit has changed by +$80.46M (+146.95%)
What is Travere Therapeutics, Inc. TTM net profit?
The current TTM net income of TVTX is -$88.54M
What is the all-time high TTM net income for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM net profit is $117.24M
What is Travere Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, TVTX TTM net profit has changed by +$260.42M (+74.63%)